Krystal Biotech Inc.

KRYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$333.85

-$2.82 (-0.84%)

At close: Sep 21, 2026, 4:00 PM ET

$333.85

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	204.83M	89.16M	10.93M	-139.98M	-69.57M	-32.17M
Depreciation & Amortization	6.55M	6.71M	5.01M	4.06M	2.77M	1.85M
Stock-Based Compensation	54.51M	49.13M	39.93M	33.23M	15.32M	3.27M
Other Working Capital	-8.84M	59.15M	8.73M	4.07M	1.34M	145K
Other Non-Cash Items	-5.77M	-7.12M	-106.79M	-690K	1.49M	33K
Deferred Income Tax	-22.85M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-36.42M	-14.46M	-37.88M	2.81M	2.05M	928K
Operating Cash Flow	200.87M	123.42M	-88.8M	-100.57M	-47.94M	-26.08M
Capital Expenditures	-11.95M	-4.24M	-11.8M	-52.98M	-68.34M	-14.84M
Cash Acquisitions	435K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-422.54M	-457.74M	-508.78M	-318.78M	-190.46M	-3.21M
Sales Maturities Of Investments	375.64M	298.54M	503.21M	257.68M	32.03M	6.87M
Other Investing Acitivies	n/a	n/a	100M	n/a	n/a	n/a
Investing Cash Flow	-58.42M	-163.44M	82.64M	-114.08M	-226.77M	-11.18M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-13.96M	-5.39M	-749K	-649K	-7.96M	n/a
Financial Cash Flow	8.71M	27.01M	202.75M	35.35M	347.69M	118.02M
Net Cash Flow	151.44M	-13.46M	196.43M	-179.35M	72.98M	80.76M
Free Cash Flow	188.91M	119.18M	-100.6M	-153.55M	-116.27M	-40.93M
Adj. Free Cash Flow	134.4M	70.06M	-140.54M	-186.78M	-131.59M	-44.2M
Maintenance CapEx	n/a	n/a	n/a	-52.98M	-68.34M	-14.84M
Growth CapEx	-11.95M	-4.24M	-11.8M	n/a	n/a	n/a
Owner Earnings	200.87M	123.42M	-88.8M	-153.55M	-116.27M	-40.93M